| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |

* Center for Cardiovascular Development and Department of Medicine;
Departments of Molecular and Cellular Biology, and Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, Texas 77030
Cardiac myocyte enlargement is the eponymous characteristic of cardiac hypertrophy, regardless of the instigating signal. Such triggers include biomechanical stress (e.g., work load, compensation for ischemic damage), sarcomeric protein mutations, cytoskeletal protein mutations, abnormal energetics, G protein-coupled receptors for ligands (including angiotensin II and endothelin-1), or their signal transducers within cells. In turn, increased myocyte size reflects increased RNA and protein content per cell as responses to these stimuli. In eukaryotic cells, the large subunit of RNA polymerase II (RNAPII) becomes extensively phosphorylated in its serine-rich C-terminal domain (CTD) during the transition from transcript initiation to transcript elongation that is, "escape" of RNAPII from the promoter-proximal region into the open reading frame. Although this process is believed to be crucial to productive synthesis of mRNA and is known to be governed by two atypical cyclin-dependent kinases, Cdk7 and Cdk9, surprisingly little is understood of how regulatory pathways within cells intersect these RNAPII-directed protein kinases. Investigations of the CTD kinase module in cardiac hypertrophy provide a tentative initial map of a molecular circuit controlling cell size through regulated phosphorylation of RNAPII.
This article has been cited by other articles:
![]() |
B. Cheng and D. H. Price Properties of RNA Polymerase II Elongation Complexes Before and After the P-TEFb-mediated Transition into Productive Elongation J. Biol. Chem., July 27, 2007; 282(30): 21901 - 21912. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Li, J. J. Cooper, G. H. Altwerger, M. D. Feldkamp, M. A. Shea, and D. H. Price HEXIM1 is a promiscuous double-stranded RNA-binding protein and interacts with RNAs in addition to 7SK in cultured cells Nucleic Acids Res., April 3, 2007; 35(8): 2503 - 2512. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Blazek, M. Barboric, J. Kohoutek, I. Oven, and B. M. Peterlin Oligomerization of HEXIM1 via 7SK snRNA and coiled-coil region directs the inhibition of P-TEFb Nucleic Acids Res., December 23, 2005; 33(22): 7000 - 7010. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Li, J. P. Price, S. A. Byers, D. Cheng, J. Peng, and D. H. Price Analysis of the Large Inactive P-TEFb Complex Indicates That It Contains One 7SK Molecule, a Dimer of HEXIM1 or HEXIM2, and Two P-TEFb Molecules Containing Cdk9 Phosphorylated at Threonine 186 J. Biol. Chem., August 5, 2005; 280(31): 28819 - 28826. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Byers, J. P. Price, J. J. Cooper, Q. Li, and D. H. Price HEXIM2, a HEXIM1-related Protein, Regulates Positive Transcription Elongation Factor b through Association with 7SK J. Biol. Chem., April 22, 2005; 280(16): 16360 - 16367. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |